to page content
to site navigation
The Resource Center has all the info you'll need From content to user feedback, the resource center has the information you need for every level of the entrepreneurial process.
Eric Ries is the author of the blog Lessons Learned. He was the co-founder and served as Chief Technology Officer of IMVU, his third startup. He is the co-author of several books including The Black Art of Java Game Programming (Waite Group Press, 1996). In 2007, BusinessWeek named Ries one of the Best Young
Entrepreneurs of Tech. He serves on the advisory board of a number of technology startups including pbWiki, Smule, 750i and KaChing.
London's Alternative Investment Market (AIM) is a credible alternative for U.S. companies looking for a market listing. As with any approach to IPO, U.S. companies should research AIM's advantages and disadvantages for listing compared with U.S. stock markets.
When Art Reisman cofounded a tech company, they had little cash and a good technology idea. Reisman shares two key bootstrapping lessons they learned: use open source technology to develop new software applications and bag indirect selling for do-it-yourself direct selling.
MotiveQuest founder, David Rabjohns, describes how he addressed key challenges in starting and growing his company--via bootstrapping--to number three in the "brand monitoring in social media" industry sector.
Fickle clients, fast growth, creative people -- crazy business! This entrepreneur watched his firm grow swiftly and his financial records become increasingly more complex, all while doing business with people whose first priority was not finishing the project on budget. He shares his experience dealing with creative workers, a quickly growing business, and his solution: strictly managed cash flow.
In the past, reverse mergers were associated with penny stocks, manipulation, and potential for abuse. Today they are viewed as a legitimate vehicle for going public. The author explains the steps involved in doing a reverse merger and offers tips for expediting filing and approval of documents with the SEC.
Angel investors in the life sciences talk about when, why and how to seek angel funding for your pharmaceutical, mobile and medical device startups.
When it comes to funding for life science companies, it isn't a matter of angel investing versus venture capital. Read about funding sources for startups.
The National Institutes of Health has billions of dollars designated for biotech research. Read about how to win NIH research grants.
Convertible debt is a fundraising mechanism used in any stage of a new healthcare business, but it may be especially appealing in the early stages.
Want to get connected? Sign up to receive regular news, polls and updates from The Kauffman Foundation.